AssistRx to Offer its iAssist Solution on the Accenture

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
242
AssistRx to Offer its iAssist Solution on the Accenture Intelligent Patient Service Exchange

ORLANDO, FL--(Marketwired - Feb 21, 2017) - AssistRx (ARx), the leading enterprise technology platform focused on specialty and highly managed medications, today announced it will make available its iAssist solution on the Accenture Intelligent Patient Service Exchange, a digital marketplace of third-party technology solutions available to life sciences companies to enhance patient support and improve the overall patient treatment experience.

The Accenture Intelligent Patient Service Exchange removes the time and cost needed to develop custom, digital patient-centric solutions by offering pre-built, plug-and-play technology connections that enable life sciences companies to integrate patient services more quickly and at a lower cost than previously possible.

Life sciences companies using the Intelligent Patient Service Exchange can leverage iAssist Workflows to onboard patients to a specialty or highly managed treatment by simplifying patient access and accelerating time-to-therapy to improve patient adherence, compliance, and outcomes.

"Today's technology solutions should simplify what are often complicated paper processes in healthcare. We streamline the prescribing process for specialty and highly managed drugs, therefore simplifying patient access, accelerating time-to-therapy, and improving patient care," said Edward Hensley, AssistRx's Chief Commercial Officer. "As part of the Accenture Intelligent Patient Service Exchange, our solution is further validated as a specialty prescribing technology platform."

The Intelligent Patient Service Exchange is embedded into the Accenture Intelligent Patient Platform -- a suite of integrated analytics-driven solutions that help life sciences companies design, deliver, measure and refine more precise support programs for patient segments.

For more information about AssistRx, visit www.assistrx.com. To learn more about Accenture's new digital marketplace of third-party technology solutions available to life sciences companies, visit Accenture Intelligent Patient Service ExchangeAccenture (NYSE: ACN) is a leading global professional services company, providing a broad range of services and solutions in strategy, consulting, digital, technology and operations.

About AssistRx

AssistRx's mission is to connect the patient-centric healthcare team through integrated technology solutions. The AssistRx Platform is a HIPAA compliant, secure, cloud-based platform that allows for the configuration of patient access workflows through its flagship product, iAssist, with acceleration services tailored to the business and therapy needs of specific drugs, and the patients that take those drugs. Using iAssist has proven to accelerate time-to-therapy by reducing the time it takes for patients to get their medications by 45%. AssistRx has built upon the success of the Platform and iAssist with a reporting and analytic platform focused on specialty and highly-managed drug therapies, eInformatix. For additional information, visit www.assistrx.com.

Media Contacts:

Caroline Congdon
Uproar PR for AssistRx
(321) 236-0102
Email Contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

International Petroleum Corporation Plans Significant Q3 Update

Updated Category News Views 206

International Petroleum Corporation's Upcoming Financial Results International Petroleum Corporation (IPC) (TSX, Nasdaq Stockholm: IPCO) is set to disclose its financial and operating outcomes for the third quarter of 2025 on an exciting date centered around important developments. This highly anticipated release will occur on a Tuesday morning, with results available at...

Continue Reading
Chris McMahon: A Leader in Financial Security Services

Updated Category News Views 109

Celebrating Chris McMahon's Achievement in Financial Security Chris McMahon, the visionary Founder and CEO of MFA Wealth, has achieved remarkable recognition within the financial services industry. Recently, he has been honored on Forbes' prestigious list of Top Financial Security Professionals for 2025, securing an impressive ranking of #61 nationally. This accolade...

Continue Reading
Exploring the Growth of the Drone Communication Market

Updated Category News Views 279

Drone Communication Market Size & Insights The Drone Communication Market is experiencing remarkable growth, projected to reach USD 5.52 billion by 2032. In 2023, this market was valued at USD 2.11 billion and is expected to grow at a significant CAGR of 11.33% from 2024 to 2032. Such impressive numbers reflect the rising demand for real-time data transmission in both...

Continue Reading
Explore the Innovative Features of Midea's TasteXpress™ Series

Updated Category News Views 276

Midea's TasteXpress™ Range Series Redefines Cooking Midea, a global leader in the home appliance industry, has once again set a standard with the unveiling of the TasteXpress™ Range Series at the highly anticipated Kitchen and Bath Industry Show. This innovative line is tailored for modern families and home chefs, combining speed, capacity, and precision cooking to...

Continue Reading
OSB Group PLC Announces Purchase of Shares on Exchange

Updated Category News Views 246

OSB Group PLC Update on Share Transactions OSB GROUP PLC ISIN: GB00BLDRH360 Date: 07 October 2025 LEI number: 213800ZBKL9BHSL2K459 Important Update from OSB GROUP PLC Share Transactions Announced The company is pleased to announce a recent transaction involving its own ordinary shares. On 6 October 2025, OSB Group purchased 90,432 shares of £0

Continue Reading